Publisher
Springer International Publishing
Reference61 articles.
1. Abraham, J. & Davis, C. (2013). Science, law, and the medico-industrial complex in EU pharmaceutical regulation: The Deferiprone controversy. In M. L. Flear, T. K. Hervey, A. M. Farrell, & T. Murphy (Eds.), European law and new health technologies (1st ed., pp. 240–255). Oxford: Oxford University Press.
https://doi.org/10.1093/acprof:oso/9780199659210.003.0011
.
2. Akobeng, A. K. (2005). Understanding randomized control trials. Archives of Disease in Childhood, 90(8), 840–844.
https://doi.org/10.1136/adc.2004.058222
.
3. Beauchamp, T. L., & Childress, J. F. (2001). Principles of biomedical ethics (5th ed.). New York, NY: Oxford University Press.
4. Beauchamp, T. L. (2007). The ‘four Principles’ approach to health care ethics. In R. E. Ashcroft, E. Dawson, H. Draper, & J. McMillan (Eds.), Principles of health care ethics (2nd ed., pp. 3–10). Chichester: Wiley.
5. Bothwell, L. E., Greene, J. A., Podolsky, S. H., & Jones, D. S. (2016). Assessing the gold standard—Lessons from the history of RCTs. New England Journal of Medicine, 374(22), 2175–2181.
https://doi.org/10.1056/NEJMms1604593
.